ID   Om5
AC   CVCL_N328
SY   OM5; URO9; URO-9
DR   ATCC; HB-8270
DR   Wikidata; Q54932023
RX   Patent=US4643971;
RX   Patent=US4935344;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8270.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen URO9 on bladder cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
RX   Patent=US4643971;
RA   Fradet Y., Cordon-Cardo C., Whitmore W.F. Jr., Melamed M.R., Old L.J.,
RA   Lloyd K.O.;
RT   "Monoclonal antibodies to human bladder and ureter cancers and
RT   method.";
RL   Patent number US4643971, 17-Feb-1987.
//
RX   Patent=US4935344;
RA   Bander N.H., Cordon-Cardo C., Finstad C.L., Whitmore W.F. Jr.,
RA   Melamed M.R., Oettgen H.F., Old L.J.;
RT   "Method for characterizing types of renal carcinoma and prognosis.";
RL   Patent number US4935344, 19-Jun-1990.
//
RX   PubMed=6364135; DOI=10.1073/pnas.81.1.224;
RA   Fradet Y., Cordon-Cardo C., Thomson T., Daly M.E., Whitmore W.F. Jr.,
RA   Lloyd K.O., Melamed M.R., Old L.J.;
RT   "Cell surface antigens of human bladder cancer defined by mouse
RT   monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:224-228(1984).
//